Despite improvements in the clinical management of aneurysmal subarachnoid haemorrhage over the last decade, delayed cerebral ischaemia (DCI) remains the single most important cause of morbidity and mortality in those patients who survive the initial bleed. The pathological mechanisms underlying DCI are still unclear and the calcium channel blocker nimodipine remains the only therapeutic intervention proven to improve functional outcomes after SAH. The recent failure of the drug clazosentan t...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm.
If you are the owner of this record, you can report an update to it here: Report update to this record